DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 146 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $315,180 | -94.0% | 20,400 | -85.7% | 0.00% | -95.0% |
| Q2 2021 | $5,233,000 | -30.5% | 142,932 | -14.9% | 0.06% | -38.1% |
| Q1 2021 | $7,530,000 | +13.2% | 167,932 | +44.0% | 0.10% | +3.2% |
| Q4 2020 | $6,654,000 | -14.6% | 116,593 | -23.3% | 0.09% | -21.0% |
| Q3 2020 | $7,796,000 | +60.3% | 151,969 | +86.6% | 0.12% | +60.8% |
| Q2 2020 | $4,864,000 | +372.7% | 81,446 | +225.8% | 0.07% | +270.0% |
| Q1 2020 | $1,029,000 | -81.4% | 25,000 | -84.7% | 0.02% | -75.0% |
| Q3 2019 | $5,532,000 | +76.2% | 162,993 | +17.1% | 0.08% | +95.1% |
| Q2 2019 | $3,139,000 | +153.8% | 139,191 | +161.2% | 0.04% | +156.2% |
| Q1 2019 | $1,237,000 | -36.6% | 53,281 | -42.7% | 0.02% | -42.9% |
| Q4 2018 | $1,952,000 | -64.4% | 93,000 | -34.3% | 0.03% | -53.3% |
| Q3 2018 | $5,483,000 | -1.6% | 141,607 | 0.0% | 0.06% | +20.0% |
| Q2 2018 | $5,572,000 | +269.0% | 141,607 | +88.0% | 0.05% | +284.6% |
| Q1 2018 | $1,510,000 | -33.7% | 75,329 | -25.0% | 0.01% | -27.8% |
| Q4 2017 | $2,276,000 | +15.7% | 100,415 | -3.1% | 0.02% | +20.0% |
| Q3 2017 | $1,968,000 | – | 103,650 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $69,030,000 | 15.95% |
| SV Health Investors, LLC | 449,951 | $25,679,000 | 12.37% |
| Sunesis Advisors, LLC | 96,299 | $5,496,000 | 4.45% |
| Redmile Group, LLC | 4,437,968 | $253,275,000 | 3.07% |
| Consonance Capital Management LP | 484,671 | $27,660,000 | 2.58% |
| SECTORAL ASSET MANAGEMENT INC | 488,842 | $27,898,000 | 1.97% |
| Opaleye Management Inc. | 222,000 | $12,670,000 | 1.66% |
| Eversept Partners, LP | 246,240 | $14,052,917 | 1.65% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 38,620 | $2,204,000 | 1.28% |
| Avoro Capital Advisors LLC | 1,300,000 | $74,191,000 | 1.28% |